Kollár, Attila (2021). Ripretinib—a new star in the firmament. Gastrointestinal Stromal Tumor, 4, p. 2. 10.21037/gist-21-3
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Kollar_2021_Ripretinib_Editorial.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (153kB) |
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Kollár, Attila |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2663-1911 |
Language: |
English |
Submitter: |
Rebeka Gerber |
Date Deposited: |
24 Nov 2021 10:33 |
Last Modified: |
05 Dec 2022 15:54 |
Publisher DOI: |
10.21037/gist-21-3 |
BORIS DOI: |
10.48350/160870 |
URI: |
https://boris.unibe.ch/id/eprint/160870 |
Actions (login required)
 |
Edit item |